Workflow
依法监管
icon
Search documents
民航局解读新修订民用航空法:全维度完善民航法治体系 为行业高质量发展护航
Core Viewpoint - The newly revised Civil Aviation Law of the People's Republic of China, consisting of 16 chapters and 262 articles, will take effect on July 1, 2026, and aims to enhance flight safety, passenger rights, and industry development [1][3]. Group 1: Flight Safety and Management - The revision strengthens flight safety and operational safety through improved airworthiness management and the establishment of a dedicated chapter on civil aviation security [3]. - It optimizes the entry conditions for transport and general aviation enterprises and increases penalties for violations [3][4]. Group 2: Industry Development - The law supports the development of new business models in general aviation and low-altitude economy, simplifying approval processes and enhancing resource allocation [3][4]. - A new chapter on "Development Promotion" outlines policies to support the civil aviation manufacturing industry, key technology research, and international cooperation [3]. Group 3: Passenger Rights Protection - The law introduces a dedicated chapter on passenger rights protection, systematizing and legalizing previous regulations [4]. - It mandates airlines to improve transport contract terms, enhance personal information protection, and optimize processes for handling flight delays or cancellations [3][4]. Group 4: Regulatory Improvements - The law encourages innovative regulatory methods using big data and emphasizes strict penalties for actions that threaten aviation safety and passenger rights [3][4]. - It expands the types and scope of administrative penalties to enhance legal deterrence [3]. Group 5: Airport Management - The revision establishes a structured legal framework for airports, categorizing them into general provisions, transport airports, and general airports [7]. - It recognizes civil airports as public infrastructure and outlines responsibilities for various stakeholders in airport construction and operation [7].
国家药监局副局长徐景和在受理和举报中心调研并开展接访下访
Core Viewpoint - The National Medical Products Administration (NMPA) emphasizes the importance of balancing safety and development, as well as regulation and service, to support high-quality industry development [1] Group 1: Regulatory Insights - The NMPA aims to implement the spirit of the 20th National Congress, focusing on legal administration and scientific regulation to effectively protect the legitimate rights and interests of enterprises [1] - There is a recognition of new challenges and tasks in the current complaint and reporting work, highlighting the need for legal thinking in addressing these issues [1] Group 2: Industry Support - The NMPA is committed to promoting social governance and achieving new results in handling complaints and reports, which is crucial for the development of the medical device and cosmetics industries [1]